College of Veterinary Medicine

Research Funding

Supporting Innovation in Antimicrobial Resistance

Funding plays a critical role in advancing our mission to combat antimicrobial resistance through groundbreaking research.

Stay tuned for updates on how research funding fuels our work, from drug discovery to vaccine development and host-pathogen studies.

Looking to Support Our Research?

We welcome inquiries from funding agencies, donors, and collaborators. Your support can help us make a lasting impact on global health. Contact us at ahmed@purdue.edu to learn more.

Funded Research and Grants

In addition to funding offered by the department of Comparative Pathobiology at Purdue University, Dr. Hassan has been awarded multiple grants to advance research in fungal pathogens, drug resistance, and immune response.

Awarded Grants

Cdc14 Phosphatase: Roles in Drug Resistance and Virulence

  • Funding Agency: National Institute of Allergy and Infectious Diseases (NIH)
  • Role: Co-Investigator
  • Principal Investigator: Dr. Mark C. Hall
  • Award Amount: $2,400,438
  • Project Duration: 03/17/2023 - 02/28/2027
  • Summary: This study explores how Cdc14 phosphatase influences virulence, drug resistance, and cell wall integrity in Candida albicans.

Development of Auxin-Inducible Degradation in Candida Pathogens

  • Funding Agency: National Institute of Allergy and Infectious Diseases (NIH)
  • Role: Co-Investigator
  • Principal Investigator: Dr. Mark C. Hall
  • Award Amount: $423,367
  • Project Duration: 08/24/2023 - 07/31/2025
  • Summary: This project aims to establish an auxin-inducible degradation system to study drug resistance and identify novel therapeutic targets in Candida species.

Antimicrobial Properties of Implant Nanosurfaces

  • Funding Agency: Nanovis Incorporated & Applied Research Institute
  • Role: Co-Investigator
  • Principal Investigator: Dr. Timothy B. Lescun
  • Award Amount: $86,124 (combined)
  • Project Duration: 09/01/2024 - 06/30/2025
  • Summary: Investigating the antimicrobial efficacy of implant nanosurfaces in soft tissue and bone integration.
Development and Evaluation of Novel Vaccines for Protection Against Clostridioides difficileInfection in Horses
  • Funding Agency: Purdue College of Veterinary Medicine
  • Role: PI
  • Award Amount: $10,000
  • Project Duration: May 1, 2024 to April 30, 2025
  • Summary: This study aims to production and evaluation of multivalent subunit vaccines against Clostridioides difficile infection (CDI) for application in horses.

Pending Grants

Augmenting Immune Response with a Novel TLR2 Agonist-Aluminum Adjuvant

  • Funding Agency: National Institutes of Health (NIH)
  • Role: Collaborator
  • Principal Investigator: Dr. Harm Hogenesch
  • Award Amount: $199,641
  • Project Duration: 07/01/2025 - 12/31/2026
  • Summary: This research evaluates a novel vaccine adjuvant for enhancing immune responses against Bordetella pertussis.

Modulating Inflammation to Improve Treatment for Clostridioides difficile Infection

  • Funding Agency: National Institutes of Health (NIH)
  • Role: Principal Investigator
  • Award Amount: $419,004
  • Project Duration: 07/01/2025 - 06/30/2027
  • Summary: This project aims to identify gut microbiota members that influence C. difficile infection outcomes and assess anti-inflammatory strategies for improving treatment efficacy.